Optimizing a therapy for opiate use disorders: Characterizing ondansetron pharmacokinetics in blood and brain

Abstract Administration of a widely used 5‐hydroxytryptamine receptor (5HT3AR) antagonist (ondansetron) potently inhibited the development of experimentally induced opioid dependence and withdrawal responses in mice and humans. However, in several studies examining withdrawal symptoms in subjects wi...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Manhong Wu (Author), Zhuanfen Cheng (Author), Anthony T. Le (Author), Yalun Tan (Author), Gary Peltz (Author)
Format: Knjiga
Izdano: Wiley, 2023-02-01T00:00:00Z.
Teme:
Online dostop:Connect to this object online.
Oznake: Označite
Brez oznak, prvi označite!